Trial intelligence / Profile preview

Acute single-dose sildenafil in COPD-associated pulmonary hypertension

2007-000116-81Phase 4Active

Sponsor
Hospital Clínic de Barcelona
Start
May 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of sildenafil in pulmonary hypertension (PH), chronic obstructive pulmonary disease (COPD) and erectile dysfunction (ED) (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoints: Mean pulmonary artery pressure, Arterial oxygen partial pressure and 2 more. Started May 2007; status: active.

02

Drugs

sildenafil
03

Conditions

pulmonary hypertension (PH)chronic obstructive pulmonary disease (COPD)erectile dysfunction (ED)

Beyond the preview

Go deeper on 2007-000116-81.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000116-81.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call